IFM Investors Pty Ltd acquired a new position in shares of Danaher Corporation (NYSE:DHR) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 17,077 shares of the conglomerate’s stock, valued at approximately $1,441,000.
A number of other institutional investors also recently made changes to their positions in DHR. Waldron LP purchased a new position in Danaher Corporation during the first quarter worth approximately $320,000. Empire Life Investments Inc. lifted its position in Danaher Corporation by 2.3% during the first quarter. Empire Life Investments Inc. now owns 77,900 shares of the conglomerate’s stock worth $6,662,000 after buying an additional 1,764 shares in the last quarter. Trust Co. of Vermont lifted its position in Danaher Corporation by 4.8% during the first quarter. Trust Co. of Vermont now owns 30,262 shares of the conglomerate’s stock worth $2,588,000 after buying an additional 1,386 shares in the last quarter. Xact Kapitalforvaltning AB lifted its position in Danaher Corporation by 50.1% during the first quarter. Xact Kapitalforvaltning AB now owns 100,549 shares of the conglomerate’s stock worth $8,600,000 after buying an additional 33,566 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Danaher Corporation by 4.2% during the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 355,219 shares of the conglomerate’s stock worth $30,382,000 after buying an additional 14,462 shares in the last quarter. Hedge funds and other institutional investors own 75.69% of the company’s stock.
DHR has been the topic of a number of analyst reports. Zacks Investment Research downgraded Danaher Corporation from a “buy” rating to a “hold” rating in a research report on Thursday, July 27th. Goldman Sachs Group, Inc. (The) reissued a “neutral” rating and set a $83.00 target price on shares of Danaher Corporation in a research note on Tuesday, September 26th. BidaskClub raised Danaher Corporation from a “sell” rating to a “hold” rating in a research note on Wednesday, July 19th. J P Morgan Chase & Co reissued an “overweight” rating and set a $95.00 target price on shares of Danaher Corporation in a research note on Friday, September 8th. Finally, Citigroup Inc. set a $96.00 target price on Danaher Corporation and gave the stock a “buy” rating in a research note on Friday, July 21st. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $92.62.
ILLEGAL ACTIVITY WARNING: “IFM Investors Pty Ltd Acquires Shares of 17,077 Danaher Corporation (DHR)” was first published by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this story on another website, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this story can be viewed at https://sportsperspectives.com/2017/10/12/ifm-investors-pty-ltd-acquires-shares-of-17077-danaher-corporation-dhr.html.
In related news, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the stock in a transaction on Monday, July 31st. The stock was sold at an average price of $81.78, for a total value of $799,154.16. Following the completion of the sale, the insider now directly owns 155,520 shares in the company, valued at approximately $12,718,425.60. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider William King sold 7,458 shares of the stock in a transaction on Friday, July 21st. The shares were sold at an average price of $82.97, for a total value of $618,790.26. Following the completion of the sale, the insider now owns 18,245 shares of the company’s stock, valued at $1,513,787.65. The disclosure for this sale can be found here. Insiders sold a total of 71,496 shares of company stock worth $5,916,223 over the last ninety days. Corporate insiders own 12.20% of the company’s stock.
Shares of Danaher Corporation (DHR) opened at 86.96 on Thursday. The stock has a 50 day moving average price of $85.55 and a 200-day moving average price of $84.19. Danaher Corporation has a 52 week low of $75.71 and a 52 week high of $88.62. The firm has a market capitalization of $60.41 billion, a PE ratio of 27.76 and a beta of 1.03.
Danaher Corporation (NYSE:DHR) last issued its earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share for the quarter, topping the consensus estimate of $0.97 by $0.02. The business had revenue of $4.51 billion for the quarter, compared to analyst estimates of $4.50 billion. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The business’s quarterly revenue was up 6.3% on a year-over-year basis. During the same period last year, the company posted $0.90 EPS. Equities analysts anticipate that Danaher Corporation will post $3.96 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, September 29th will be given a $0.14 dividend. This represents a $0.56 annualized dividend and a dividend yield of 0.64%. The ex-dividend date is Thursday, September 28th. Danaher Corporation’s dividend payout ratio (DPR) is currently 17.83%.
Danaher Corporation Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.